Rob Krukowski

Sr. Director, Value, Access & Pricing at SpringWorks Therapeutics

Rob Krukowski has a diverse work experience spanning over two decades. Rob is currently working at SpringWorks Therapeutics as the Sr. Director of Value, Access & Pricing. Prior to that, they worked at Regeneron where they held various roles including Sr. Director of Marketing - Oncology, Sr. Director of Commercial Effectiveness - Oncology, and Head of Patient Access Services. During their time at Regeneron, they played a crucial role in identifying organizational gaps and implementing successful approaches. Rob also led all aspects of market access strategy and execution for EYLEA®. Before joining Regeneron, Rob worked at Sanofi Genzyme as a Sr. Product Manager and Product Manager in different marketing roles. Rob began their career at The Janssen Pharmaceutical Companies of Johnson & Johnson as a Product Specialist. Rob also gained experience in the finance industry at ABN AMRO and Vanguard. Overall, Rob's work experience demonstrates their expertise in marketing, access services, and leadership roles in the pharmaceutical and finance sectors.

Rob Krukowski completed a Bachelor of Science degree in Finance, with a minor in Management Information Systems, from the University of Delaware in the years 1999 to 2003. At a later point, they also pursued an Executive Education program in Strategic Marketing Management at Harvard Business School.

Links

Previous companies

Sanofi logo
ABN AMRO logo
Regeneron logo
Vanguard logo

Timeline

  • Sr. Director, Value, Access & Pricing

    September, 2023 - present

  • Head Of Patient Services And Field Access Managers

    August, 2021